Prihlásiť sa Zaregistrujte sa zadarmo

Návratnosť imania spoločnosti Adaptimmune Therapeutics Plc

Aká je hodnota metriky Návratnosť imania spoločnosti Adaptimmune Therapeutics Plc?

Hodnota metriky Návratnosť imania spoločnosti Adaptimmune Therapeutics Plc je -116.80%

Aká je definícia metriky Návratnosť imania?



Návratnosť imania (Return on equity - ROE) je rentabilita vlastného imania. Vypočíta sa vydelením čistého príjmu za fiškálny rok vlastným imaním.

The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.

Návratnosť imania spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Adaptimmune Therapeutics Plc

Čomu sa venuje spoločnosť Adaptimmune Therapeutics Plc?

adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.

Firmy s metrikou návratnosť imania podobnou spoločnosti Adaptimmune Therapeutics Plc